191 related articles for article (PubMed ID: 6417248)
1. Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro.
Bedord CJ; Young JM; Wagner BM
J Invest Dermatol; 1983 Dec; 81(6):566-71. PubMed ID: 6417248
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.
Huang MT; Lysz T; Ferraro T; Abidi TF; Laskin JD; Conney AH
Cancer Res; 1991 Feb; 51(3):813-9. PubMed ID: 1899046
[TBL] [Abstract][Full Text] [Related]
3. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Schröder JM
J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
[TBL] [Abstract][Full Text] [Related]
4. Arachidonate metabolism in the mouse thyroid implication of the lipoxygenase pathway in thyrotropin action.
Levasseur S; Sun FF; Friedman Y; Burke G
Prostaglandins; 1981 Oct; 22(4):663-73. PubMed ID: 6275458
[TBL] [Abstract][Full Text] [Related]
5. Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets.
Dragan YP; Ellis EF
Biochem Pharmacol; 1990 Jan; 39(1):27-32. PubMed ID: 2105095
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse epidermal 12-lipoxygenase by 2,3,4-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinon e (AA861).
Nakadate T; Yamamoto S; Aizu E; Kato R
J Pharm Pharmacol; 1985 Jan; 37(1):71-3. PubMed ID: 2858536
[TBL] [Abstract][Full Text] [Related]
7. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
8. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
[TBL] [Abstract][Full Text] [Related]
9. Dermis-derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity.
Kragballe K; Pinnamaneni G; Desjarlais L; Duell EA; Voorhees JJ
J Invest Dermatol; 1986 Oct; 87(4):494-8. PubMed ID: 3093592
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins.
Kimura Y; Okuda H; Arichi S; Baba K; Kozawa M
Biochim Biophys Acta; 1985 Apr; 834(2):224-9. PubMed ID: 3922420
[TBL] [Abstract][Full Text] [Related]
11. Modulation of insulin secretion by lipoxygenase products of arachidonic acid. Relation to lipoxygenase activity of pancreatic islets.
Yamamoto S; Ishii M; Nakadate T; Nakaki T; Kato R
J Biol Chem; 1983 Oct; 258(20):12149-52. PubMed ID: 6415050
[TBL] [Abstract][Full Text] [Related]
12. Effects of reactive oxygen species on the biosynthesis of 12 (S)-hydroxyeicosatetraenoic acid in mouse epidermal homogenate.
Müller K; Gawlik I
Free Radic Biol Med; 1997; 23(2):321-30. PubMed ID: 9199895
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid.
Werner EJ; Walenga RW; Dubowy RL; Boone S; Stuart MJ
Cancer Res; 1985 Feb; 45(2):561-3. PubMed ID: 3917850
[TBL] [Abstract][Full Text] [Related]
14. Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release.
Metz S; VanRollins M; Strife R; Fujimoto W; Robertson RP
J Clin Invest; 1983 May; 71(5):1191-205. PubMed ID: 6406544
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
17. 15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease.
Setty BN; Stuart MJ
J Clin Invest; 1986 Jan; 77(1):202-11. PubMed ID: 3080473
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolism in guinea pig skin: effects of chloroquine.
Ruzicka T; Printz MP
Agents Actions; 1982 Oct; 12(4):527-9. PubMed ID: 6817622
[TBL] [Abstract][Full Text] [Related]
19. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
Müller K; Huang HS; Wiegrebe W
J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
[TBL] [Abstract][Full Text] [Related]
20. Feedback regulation of platelet function by 12S-hydroxyeicosatetraenoic acid: inhibition of arachidonic acid liberation from phospholipids.
Sekiya F; Takagi J; Sasaki K; Kawajiri K; Kobayashi Y; Sato F; Saito Y
Biochim Biophys Acta; 1990 May; 1044(1):165-8. PubMed ID: 2111172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
